Dedicated to improving reproductive medicine. Nora is committed to the scientific development of therapeutics to address unmet clinical needs in reproductive medicine.


Nora’s technology seeks to optimize the maternal-fetal interface to improve the likelihood of a successful implantation and birth.

Learn more

News & Events

Nora Therapeutics Announces $18 Million Series B Financing

Learn more

Clinical Trials

Nora has initiated Thrive-IVF, a phase 2 clinical trial of its lead drug candidate, NT100, in women with a history of repeated in vitro fertilization (IVF) failures.

Learn more